Mavroudis Constantine, Deal Barbara J, Backer Carl L
Division of Cardiovascular-Thoracic Surgery, Children's Memorial Hospital, Chicago, IL 60614, USA.
Int J Cardiol. 2004 Dec;97 Suppl 1:39-51. doi: 10.1016/j.ijcard.2004.08.008.
Transcatheter radiofrequency ablation to treat supraventricular and ventricular arrhythmias has supplanted routine surgical ablative therapy and redefined its role. A small population of arrhythmia patients now requires surgical ablation: those who have failed catheter ablation, patients with concomitant congenital heart disease in association with arrhythmias, those with atrial fibrillation and very young patients for whom transcatheter techniques are prohibitive because of small size, cyanosis or distorted anatomy.
From July 1992 through August 2003, 133 patients underwent arrhythmia surgery at Children's Memorial Hospital, 50% (67/133) in association with Fontan conversion (FC), 22% (28/133) with concomitant initial Fontan (IF) procedure and 28% (38/133) for various arrhythmias (MISC) in patients with (36/38, 95%) or without (2/38, 5%) associated structural heart disease. Mean age at surgery in the FC group was 20+/-7.6 years (median 19 years), and in the IF group and the MISC group, mean ages were 8.1+/-8.9 (median 4.2) years and 16.4+/-10.9 (median 11.3) years, respectively.
There were three operative (3/133, 2.6%; 1 FC, 2 MISC) and three late deaths (2 FC, 1 MISC). Four patients in the FC group had progressive ventricular failure and underwent successful cardiac transplantation. Follow-up data are available for non-transplant, surviving patients and reveal 11 incidences of persistent arrhythmia recurrence and 2 new-onset arrhythmias. Five of the 11 recurrences occurred early in our series of FC patients, when isthmus block interruption of arrhythmia foci was performed. Four additional recurrences occurred later in the FC series, two post-maze and two post-Cox-maze III. In the MISC group, there were two recurrences. Atrial reentry tachycardia (ART) recurred in a patient with no structural heart disease and accessory connection-mediated tachycardia recurred in a child who underwent concomitant initial Fontan. Two patients had ventricular tachycardia inducible at postoperative studies (2/7, 29%), but no clinical recurrence. Two new-onset tachycardias occurred, one child developed ART post-surgical ablation of accessory connections and one patient with inducible ventricular tachycardia developed ART 5 years postoperatively.
Variations in atrial and ventricular anatomy that may limit the catheter approach can be addressed surgically. Patient size or anatomic complexity should not be limiting factors in the combined surgical arrhythmia approach. Incorporation of arrhythmia therapy into planned surgical revision should be considered.
经导管射频消融治疗室上性和室性心律失常已取代常规外科消融治疗,并重新定义了其作用。现在只有一小部分心律失常患者需要进行外科消融:那些导管消融失败的患者、伴有先天性心脏病合并心律失常的患者、心房颤动患者以及因体型小、发绀或解剖结构异常而无法采用经导管技术的非常年轻的患者。
从1992年7月至2003年8月,133例患者在儿童纪念医院接受了心律失常手术,其中50%(67/133)与Fontan转换(FC)相关,22%(28/133)与同期初次Fontan(IF)手术相关,28%(38/133)用于治疗各种心律失常(MISC),这些患者伴有(36/38,95%)或不伴有(2/38,5%)相关结构性心脏病。FC组手术时的平均年龄为20±7.6岁(中位数19岁),IF组和MISC组的平均年龄分别为8.1±8.9岁(中位数4.2岁)和16.4±10.9岁(中位数11.3岁)。
有3例手术死亡(3/133,2.6%;1例FC,2例MISC)和3例晚期死亡(2例FC,1例MISC)。FC组有4例患者出现进行性心力衰竭并成功接受了心脏移植。有非移植存活患者的随访数据,显示有11例持续性心律失常复发和2例新发心律失常。11例复发中有5例发生在我们的FC患者系列早期,当时进行了峡部阻滞以中断心律失常病灶。FC系列后期又有4例复发,2例在迷宫手术后,2例在Cox迷宫III手术后。在MISC组,有2例复发。无结构性心脏病的患者发生了房性折返性心动过速(ART),接受同期初次Fontan手术的儿童发生了房室旁道介导的心动过速复发。2例患者在术后检查中可诱发室性心动过速(2/7,29%),但无临床复发。发生了2例新发心动过速,1例儿童在外科消融房室旁道后发生了ART,1例可诱发室性心动过速的患者在术后5年发生了ART。
可能限制导管操作的心房和心室解剖结构变异可通过手术解决。患者体型或解剖复杂性不应成为联合外科心律失常治疗方法的限制因素。应考虑将心律失常治疗纳入计划中的外科翻修手术。